Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting

Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. The knowledge of the pathogenesis and neuropharmacology of CINV has expanded enormously over the last decades, the most significant discoveries being the role of 5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruhlmann, Christina, Herrstedt, Jørn
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697542/
https://www.ncbi.nlm.nih.gov/pubmed/19536319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697542/
https://www.ncbi.nlm.nih.gov/pubmed/19536319

Ejemplares similares